Populus balsamifera L. (Salicaceae) mitigates the development of obesity and improves insulin sensitivity in a diet-induced obese mouse model

Journal of Ethnopharmacology

Volumn 141, Issue 3, 2012, Pages 1012-1020

  Harbilas, Despina ^a,b,c   Brault, Antoine ^a,b,c   Vallerand, Diane ^a,b,c   Martineau, Louis C ^a,b,c   Saleem, Ammar ^a,c,d   Arnason, John T ^a,c,d   Musallam, Lina ^a,b,c   Haddad, Pierre S ^a,b,c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Adipokines; Balsam poplar; C57BL 6 mice; IKK ; p44 42 MAPK; Skin temperature

Indexed keywords

ADIPONECTIN; ANTIOBESITY AGENT; GLUCOSE; LEPTIN; PLANT EXTRACT; POPULUS BALSAMIFERA EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; ASPEN; CELL DIFFERENTIATION; CONTROLLED STUDY; DIETARY INTAKE; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; ENERGY EXPENDITURE; FATTY ACID OXIDATION; FATTY LIVER; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; INSULIN SENSITIVITY; LIPID DIET; MALE; MEDICINAL PLANT; METABOLIC SYNDROME X; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; RETROPERITONEAL FAT; SKIN TEMPERATURE;

ADIPOSE TISSUE; ANIMALS; ANTI-OBESITY AGENTS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; LIVER; MALE; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OBESITY; PLANT EXTRACTS; POPULUS; SKIN TEMPERATURE; TRIGLYCERIDES;

MUS; POPULUS BALSAMIFERA; SALICACEAE;

EID: 84861332296     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2012.03.046     Document Type: Article

References (47)

1. F. Abbasi, J.W. Chu, C. Lamendola, T. McLaughlin, J. Hayden, G.M. Reaven, and P.D. Reaven Discrimination between obesity and insulin resistance in the relationship with adiponectin Diabetes 53 2004 585 590
2. Alberti, K.G.; Zimmet P.; et al.; 2006. "Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation." Diabetes Medicine 23(5): 469-480.
3. M.C. Arkan, A.L. Hevener, F.R. Greten, S. Maeda, Z.W. Li, J.M. Long, A. Wynshaw-Boris, G. Poli, J. Olefsky, and M. Karin IKK-beta links inflammation to obesity-induced insulin resistance Nature Medicine 11 2005 191 198
4. J.T. Arnason, R.J. Hebda, and T. Johns Use of plants for food and medicine by Native Peoples of Eastern Canada Canadian Journal of Botany 59 1981 2189 2325
5. E.M. Brunt, C.G. Janney, A.M. Di Bisceglie, B.A. Neuschwander-Tetri, and B.R. Bacon Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions American Journal of Gastroenterology 94 1999 2467 2474
6. R. Buettner, J. Scholmerich, and L.C. Bollheimer High-fat diets: modeling the metabolic disorders of human obesity in rodents Obesity (Silver Spring) 15 2007 798 808
7. H.S. Camp, and S.R. Tafuri Regulation of peroxisome proliferator- activated receptor gamma activity by mitogen-activated protein kinase Journal of Biological Chemistry 272 1997 10811 10816
8. N.C. Chavez-Tapia, N. Mendez-Sanchez, and M. Uribe Role of nonalcoholic fatty liver disease in hepatocellular carcinoma Annals of Hepatology 8 2009 S34 S39
9. S. Collins, T.L. Martin, R.S. Surwit, and J. Robidoux Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics Physiology and Behaviour 81 2004 243 248
10. R. Dallmann, S. Steinlechner, S. von Horsten, and T. Karl Stress-induced hyperthermia in the rat: comparison of classical and novel recording methods LabAnimal 40 2006 186 193
11. Dannenbaum, D.; Kuzmina, E.; Torrie, J.; 2010. Clinical Management of Diabetes in Eeyou Istchee - 2009: Internal Report for healthcare workers. In: r.B.o.H.a.S.S.o.J. Bay (Ed.), Public Health Report Series 3 on Diabetes. Chisasibi, Quebec.
12. Dannenbaum, D.; Kuzmina, E.; Gangbè, M.; Torrie, J.; 2008. Diabetes clinical management in Iiyiyiu Aschii (2006). Cree Board of Health and Social Services of James Bay. Quebec. 14.
13. M. den Boer, P.J. Voshol, F. Kuipers, L.M. Havekes, and J.A. Romijn Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models Arteriosclerosis, Thrombosis, and Vascular Biology 24 2004 644 649
14. E. Donzelli, C. Lucchini, E. Ballarini, A. Scuteri, F. Carini, G. Tredici, and M. Miloso ERK1 and ERK2 are involved in recruitment and maturation of human mesenchymal stem cells induced to adipogenic differentiation Journal of Molecular Cell Biology 3 2010 123 131
15. M.S. Eberhardt, C. Ogden, M. Engelgau, B. Cadwell, A.A. Hedley, and S.H. Saydah Prevalence of overweight and obesity among adults with diagnosed diabetes - United States, 1988-1994 and 1999-2002 2004 CDC, and Department of Health and Human services
16. F.M. Finucane, J. Luan, N.J. Wareham, S.J. Sharp, S. O'Rahilly, B. Balkau, A. Flyvbjerg, M. Walker, K. Hojlund, J.J. Nolan, and D.B. Savage Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals Diabetologia 2009
17. M.H. Fraser, A. Cuerrier, P.S. Haddad, J.T. Arnason, P.L. Owen, and T. Johns Medicinal plants of Cree communities (Quebec Canada): antioxidant activity of plants used to treat type 2 diabetes symptoms Canadian Journal of Physiology and Pharmacology 85 2007 1200 1214
18. E.S. Freedland Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review Nutrition and Metabolism (Lond.) 1 2004 12
19. D. Garriguet Obesity and the Eating Habits of the Aboriginal Population 2008 Statistics Canada
20. J. Girard, and M. Lafontan Impact of visceral adipose tissue on liver metabolism and insulin resistance. Part II: Visceral adipose tissue production and liver metabolism Diabetes Metabolism 34 2008 439 445
21. S.M. Grundy Drug therapy of the metabolic syndrome: minimising the emerging crisis in polypharmacy Nature Reviews Drug Discovery 5 2006 295 309
22. Y. Haddad, D. Vallerand, A. Brault, and P.S. Haddad Antioxidant and hepatoprotective effects of silibinin in a rat model of nonalcoholic steatohepatitis Evidence Based Complementary Alternative Medicine 2009
23. Y. Haddad, D. Vallerand, A. Brault, J. Spenard, and P.S. Haddad NCX 1000 alone or in combination with vitamin e reverses experimental nonalcoholic steatohepatitis in the rat similarly to UDCA International Jouranl of Hepatology 2011 2011 136816
24. D. Harbilas, L.C. Martineau, C.S. Harris, D.C. Adeyiwola-Spoor, A. Saleem, J. Lambert, D. Caves, T. Johns, M. Prentki, A. Cuerrier, J.T. Arnason, S.A. Bennett, and P.S. Haddad Evaluation of the antidiabetic potential of selected medicinal plant extracts from the Canadian boreal forest used to treat symptoms of diabetes, part II Canadian Journal of Physiology and Pharmacology 87 2009 479 492
25. E. Hu, J.B. Kim, P. Sarraf, and B.M. Spiegelman Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma Science 274 1996 2100 2103
26. J.K. Kim, Y.J. Kim, J.J. Fillmore, Y. Chen, I. Moore, J. Lee, M. Yuan, Z.W. Li, M. Karin, P. Perret, S.E. Shoelson, and G.I. Shulman Prevention of fat-induced insulin resistance by salicylate Journal of Clinical Investigation 108 2001 437 446
27. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, O.W. Cummings, L.D. Ferrell, Y.C. Liu, M.S. Torbenson, A. Unalp-Arida, M. Yeh, A.J. McCullough, and A.J. Sanyal Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
28. C. Leduc, J. Coonishish, P. Haddad, and A. Cuerrier Plants used by the Cree Nation of Eeyou Istchee (Quebec, Canada) for the treatment of diabetes: a novel approach in quantitative ethnobotany Journal of Ethnopharmacology 105 2006 55 63
29. A.L. Leighton Wild Plant Use by the Woods Cree (Nihithawak) of East-Central Saskatchewan. National Museums of Man Mercury Series 101 1985 Canadian Ethnology Service Ottawa, Ontario, Canada
30. R.J. Marles, and N.R. Farnsworth Antidiabetic plants and their active constituents Phytomedicine 2 1995 137 189
31. R.J. Marles, C. Clavelle, L. Monteleone, N. Tays, and D. Burns Aboriginal Plant Use in Canada's Northwest Boreal Forest 2000 UBC Press Vancouver
32. L.C. Martineau, J. Herve, A. Muhammad, A. Saleem, C.S. Harris, J.T. Arnason, and P.S. Haddad Anti-adipogenic activities of Alnus incana and Populus balsamifera bark extracts. Part I: Sites and mechanisms of action Planta Medica 2010
33. L.C. Martineau, A. Muhammad, A. Saleem, J. Herve, C.S. Harris, J.T. Arnason, and P.S. Haddad Anti-adipogenic activities of Alnus incana and Populus balsamifera bark extracts. Part II: Bioassay-guided identification of activities salicortin and oregonin Planta Medica 2010
34. D. Moerman Native American Ethnobotany 1998 Timber Press Portland
35. N.M. Morton, V. Densmore, M. Wamil, L. Ramage, K. Nichol, L. Bunger, J.R. Seckl, and C.J. Kenyon A polygenic model of the metabolic syndrome with reduced circulating and intra-adipose glucocorticoid action Diabetes 54 2005 3371 3378
36. J. Oben, D. Kuate, G. Agbor, C. Momo, and X. Talla The use of a Cissus quadrangularis formulation in the management of weight loss and metabolic syndrome Lipids in Health and Disease 5 2006 24
37. PHAC Obesity in Canada - Snapshot 2009
38. Diabetes among First Nations, Inuit, and Métis populations Diabetes in Canada: Facts and figures from a public health perspective 2011 (Chapter 6)
39. PHAC Obesity in Canada: A Joint Report from the Public Health Agency of Canada and the Canadian Institute for Health Information 2011
40. Statistics Canada Canadian community Health Survey: Obesity among children and adults The Daily 2005
41. H.S. Sul Minireview: Pref-1: role in adipogenesis and mesenchymal cell fate Molecular Endocrinology 23 2009 1717 1725
42. O. Tschritter, A. Fritsche, C. Thamer, M. Haap, F. Shirkavand, S. Rahe, H. Staiger, E. Maerker, H. Haring, and M. Stumvoll Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism Diabetes 52 2003 239 243
43. C. Weyer, T. Funahashi, S. Tanaka, K. Hotta, Y. Matsuzawa, R.E. Pratley, and P.A. Tataranni Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia Journal of Clinical Endocrinology and Metabolism 86 2001 1930 1935
44. WHO Obesity and Overweight Fact sheet 2011 p. 311
45. D. Withrow, and D.A. Alter The economic burden of obesity worldwide: a systematic review of the direct costs of obesity Obesity Reviews 12 2010 131 141
46. Y. Yamamoto, H. Hirose, I. Saito, M. Tomita, M. Taniyama, K. Matsubara, Y. Okazaki, T. Ishii, K. Nishikai, and T. Saruta Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population Clinical Science (Lond.) 103 2002 137 142
47. M. Yuan, N. Konstantopoulos, J. Lee, L. Hansen, Z.W. Li, M. Karin, and S.E. Shoelson Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta Science 293 2001 1673 1677